A positive COVID-19 case in the workplace or school puts employees, students, teachers, and others at risk, and slow turnaround times for testing create a spiral of negative effects for everyone. Having a strong COVID-19 screening plan in place for early detection is critical in the fight to prevent further spread of the virus.
Cordant Health Solutions® is now offering fast and cost-effective RT-PCR COVID-19 saliva testing solutions, focusing on serving organizations in the Pacific Northwest through our laboratory located in Tacoma, Washington.
Cordant’s program offers competitive pricing and includes robust reporting capabilities.
Test results are typically available within 24 hours of the sample being received by Cordant.
Cordant uses a saliva test that detects the virus that causes COVID-19.* The saliva sample is easily collected and then sent back to Cordant for testing.
A positive COVID-19 case in your school puts teachers, staff, students and families at risk of exposure to the virus. Regular screening for early detection helps keep everyone safe and kids and teachers in the classroom.
Saliva testing is also easier for younger children to provide samples and helps to create greater participation.
As many destinations begin reopening and business travel resumes, having a COVID-19 pre-flight screening plan in place for your employees will help save your business time and money that can be lost due to lengthy and avoidable quarantine periods.
Cordant is one of the only test providers able to deliver COVID-19 RT-PCR saliva test results within 24 hours, providing an ideal solution for your traveling workforce needs.
Cordant is able to accept overflow testing for organizations and laboratories experiencing high demand for testing.
For over 30 years, Cordant Health Solutions has operated as a high-volume clinical laboratory with scientific expertise and strict quality standards with a long history of supporting local and state agencies, employers, and community programs.
Cordant is certified under the Clinical Laboratory Improvement Amendment (CLIA), registered with the International Reagent Resource (IRR), and authorized by the Washington State Health Care Authority to perform COVID-19 testing.
*Cordant uses the SalivaDirect™ Test qualitative detection of nucleic acid from SARS-CoV-2 in saliva. This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
If you would like to learn more about Cordant’s COVID-19 testing program, complete the form below and a representative will contact you shortly.